Deep Vein Thrombosis: Diagnosis & Treatment Reginald E. Smith ...
Deep Vein Thrombosis: Diagnosis & Treatment Reginald E. Smith ...
Deep Vein Thrombosis: Diagnosis & Treatment Reginald E. Smith ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Major bleeding rates<br />
3.50<br />
3.00<br />
2.50<br />
RR 0.80 (95% CI: 0.69–0.93)<br />
2.71<br />
p=0.003 (sup)<br />
RRR<br />
20%<br />
RR 0.93 (95% CI: 0.81–1.07)<br />
3.11<br />
p=0.31 (sup)<br />
3.36<br />
% per year<br />
2.00<br />
1.50<br />
1.00<br />
0.50<br />
0.00<br />
D110 mg BID D150 mg BID Warfarin<br />
Connolly SJ., et al. NEJM published online on Aug 30th 2009.<br />
DOI 10.1056/NEJMoa0905561<br />
322 / 6,015 375 / 6,076 397 / 6,022<br />
Dabigatran etexilate is in clinical development and not licensed for<br />
clinical use in stroke prevention for patients with atrial fibrillation
Change language